demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only
COVID-19 severe or critically
COVID-19 severe or critically
miscellaneous
pyridostigmine Fragoso-Saavedra ...

3 studies excluded by filtering options 0

4960 Ming Zhong, 2020 113high risk of bias
5620 Mansour, 0 010selection pending
6973 ACTIV-3 Critical Care, 2022 110risk of bias not avaialble